Skip to content
TrialScanner

NCT06391593

PD, PK, and Safety of ALTO-203 in Patients With MDD

Phase 2CompletedANROLead

Registry record

Lead sponsor
Alto Neuroscience
Conditions
Major Depressive Disorder; Anhedonia
Primary completion
Apr 14, 2025Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT06391593 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT06391593: PD, PK, and Safety of... | TrialScanner